GlassScriptPhysician profile
Robert F Laprade
NPI 1477658771
$1,149,077.11
in general payments reported to CMS, 2019-2025
11 companies · $202K in 2025
The $202K reported for 2025 was more than what 98% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108K · 2020: $142K · 2021: $88K · 2022: $178K · 2023: $201K · 2024: $230K · 2025: $202K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $192K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $191K · Consulting Fee: $172K · Travel and Lodging: $60K · Food and Beverage: $9,480 · Honoraria: $7,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $191,552.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $191,100.00 |
| Consulting Fee | $172,462.50 |
| Travel and Lodging | $60,241.94 |
| Food and Beverage | $9,480.17 |
| Honoraria | $7,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,112,260.62 | 2019-2025 | Spatial Frame, Novostitch, Acufex |
| Responsive Arthroscopy INC | $14,965.00 | 2023-2025 | Responsive Arthroscopy Devices |
| Ossur Americas, INC. | $9,649.33 | 2024-2025 | Unloader One X, Miami J |
| Arthrex, INC. | $8,225.00 | 2019-2024 | |
| Linvatec Corporation | $2,413.05 | 2019-2020 | |
| Foundation Medical, LLC | $1,263.96 | 2022 | |
| Miach Orthopaedics, INC. | $124.47 | 2024 | |
| Gemini Medical LLC | $81.88 | 2020 | |
| Vericel Corporation | $49.39 | 2024 | Maci |
| Stryker Corporation | $28.56 | 2022 | |
| Avanos Medical | $15.85 | 2023 | Grpro 2.1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$802,666.69 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Laprade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.